Reference
[Please submit your publication]
|
Duncan OF, Granat L, Ranganathan R, Singh VK, Mazaud D, Fanto M, Chambers D, Ballard CG, Bateman JM. Ras-ERK-ETS inhibition alleviates neuronal mitochondrial dysfunction by reprogramming mitochondrial retrograde signaling. PLoS Genet (2018) 14(7) e1007567
[
PubMed ID = 30059502
]
[
RRC reference
]
|
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
100 |
482 |
0 |
0 |
0 |
NM_135348.2 |
CG8451-RA (CG8451), mRNA |
1.45 |
7 |
3 |
2 |
8 |
NM_143634.2 |
CG2191-RA (CG2191), mRNA |
0 |
0 |
3 |
2 |
4 |
NM_142336.1 |
CG3983-RB, transcript variant B (CG3983), mRNA |
0 |
0 |
3 |
2 |
4 |
NM_169742.1 |
CG3983-RA, transcript variant A (CG3983), mRNA |
0 |
0 |
3 |
2 |
3 |
NM_166757.1 |
CG1710-RC, transcript variant C (Hcf), mRNA |
0 |
0 |
3 |
2 |
3 |
NM_166756.1 |
CG1710-RB, transcript variant B (Hcf), mRNA |
0 |
0 |
3 |
2 |
3 |
NM_079882.2 |
CG1710-RA, transcript variant A (Hcf), mRNA |
0 |
0 |
3 |
2 |
3 |
NM_205873.1 |
CG1710-RD, transcript variant D (Hcf), mRNA |
0 |
0 |
2 |
3 |
2 |
NM_176177.1 |
CG33139-RA (Ranbp11), mRNA |
0 |
0 |
2 |
2 |
3 |
NM_130601.2 |
CG32803-RA, transcript variant A (CG32803), mRNA |
0 |
0 |
2 |
2 |
3 |
NM_001038733.1 |
CG32803-RB, transcript variant B (CG32803), mRNA |
0 |
0 |
1 |
4 |
5 |
NM_001043174.1 |
CG40053-RA (CG40053), mRNA |
0 |
0 |
1 |
4 |
5 |
NM_001043173.1 |
CG40044-RA (CG40044), mRNA |
0 |
0 |
1 |
3 |
3 |
NM_170466.1 |
CG31025-RA, transcript variant A (CG31025), mRNA |
0 |
0 |
1 |
3 |
3 |
NM_170467.1 |
CG31025-RB, transcript variant B (CG31025), mRNA |
0 |
0 |
0 |
16 |
42 |
NM_175948.1 |
CG33124-RA (CG33124), mRNA |
0 |
0 |
0 |
15 |
37 |
NM_169752.1 |
CG31262-RA (CG31262), mRNA |
0 |
0 |
0 |
6 |
4 |
NM_205883.1 |
CG4574-RD, transcript variant D (Plc21C), mRNA |
0 |
0 |
0 |
6 |
4 |
NM_057503.4 |
CG4574-RB, transcript variant B (Plc21C), mRNA |
0 |
0 |
0 |
6 |
4 |
NM_205882.1 |
CG4574-RF, transcript variant F (Plc21C), mRNA |
0 |
0 |
0 |
6 |
4 |
NM_205884.1 |
CG4574-RC, transcript variant C (Plc21C), mRNA |
0 |
0 |
0 |
6 |
4 |
NM_057504.4 |
CG4574-RA, transcript variant A (Plc21C), mRNA |
0 |
0 |
0 |
4 |
3 |
NM_140842.1 |
CG9629-RA (CG9629), mRNA |
0 |
0 |
0 |
3 |
10 |
NM_132169.1 |
CG9657-RA (CG9657), mRNA |
0 |
0 |
0 |
3 |
7 |
NM_131997.1 |
CG16752-RA (CG16752), mRNA |
0 |
0 |
0 |
3 |
6 |
NM_206521.1 |
CG4257-RF, transcript variant F (Stat92E), mRNA |
0 |
0 |
0 |
3 |
6 |
NM_206520.1 |
CG4257-RE, transcript variant E (Stat92E), mRNA |
0 |
0 |
0 |
3 |
5 |
NM_130656.2 |
CG9904-RA (CG9904), mRNA |
0 |
0 |
0 |
3 |
5 |
NM_143410.2 |
CG11874-RA (CG11874), mRNA |
0 |
0 |
0 |
3 |
4 |
NM_143585.2 |
CG11318-RA (CG11318), mRNA |
|